All Stories

  1. Systematic review and meta-analysis for a Global Patient co-Owned Cloud (GPOC)
  2. Protocol to dissect and dissociate the mouse brainstem for single-cell RNA-seq applications
  3. Technical Sandbox for a Global Patient co-Owned Cloud (GPOC)
  4. A Summit on a Global Patient co-Owned Cloud (GPOC)
  5. Review of the Ethics, Policies and Regulations of a Global Patient co-Owned Cloud (GPOC)
  6. Mechanical ventilation induces brainstem inflammation in preterm fetal sheep
  7. Does fetal growth restriction induce neuropathology within the developing brainstem?
  8. Necessity of a Global Patient co-Owned Cloud (GPOC)
  9. Systematic Review and Meta-Analysis for a Global Patient co-Owned Cloud (GPOC)
  10. Weight a minute: The smaller and more immature, the more predictable the autonomic regulation?
  11. Vital sign‐based detection of sepsis in neonates using machine learning
  12. The cerebrospinal fluid proteome of preterm infants predicts neurodevelopmental outcome
  13. Prostaglandin E2 Exerts Biphasic Dose Response on the PreBötzinger Complex Respiratory-Related Rhythm
  14. The effect of the delta SARS-CoV-2 variant on maternal infection and pregnancy
  15. Auxilin is a novel susceptibility gene for congenital heart block which directly impacts fetal heart function
  16. Classification and feature extraction for neonatal sepsis detection
  17. Increased Prostaglandin E2 in Brainstem Respiratory Centers Is Associated With Inhibition of Breathing Movements in Fetal Sheep Exposed to Progressive Systemic Inflammation
  18. Proteomic profiles in cerebrospinal fluid predicted death and disability in term infants with perinatal asphyxia: A pilot study
  19. Potential role of neurofilament in COVID-19 and preeclampsia
  20. Neonatal sepsis prediction through clinical decision support algorithms: A systematic review
  21. Persistent symptoms in Swedish children after hospitalisation due to COVID‐19
  22. Reduction in paediatric emergency visits during the COVID‐19 pandemic in a region with open preschools and schools
  23. Is There an Effect of Fetal Mesenchymal Stem Cells in the Mother–Fetus Dyad in COVID-19 Pregnancies and Vertical Transmission?
  24. AIM in Neonatal and Paediatric Intensive Care
  25. Presynaptic dysfunction in CASK-related neurodevelopmental disorders
  26. Paediatric COVID‐19 admissions in a region with open schools during the two first months of the pandemic
  27. Hidden Markov Models for Sepsis Detection in Preterm Infants
  28. Urinary PGE 2 metabolite levels in hospitalised infants with infections compared to age‐matched controls
  29. Cognitive Development Trajectories in Preterm Children With Very Low Birth Weight Longitudinally Followed Until 11 Years of Age
  30. Self-reported Quality of Life at Middle School Age in Survivors of Very Preterm Birth
  31. Fas-ligand and interleukin-6 in the cerebrospinal fluid are early predictors of hypoxic-ischemic encephalopathy and long-term outcomes after birth asphyxia in term infants
  32. Astrocyte Networks Modulate Respiration Sniffing Glue
  33. Neurobehavioral Outcomes 11 Years After Neonatal Caffeine Therapy for Apnea of Prematurity
  34. Astrocytic stars participate in and modify brainstem networks that generate breathing
  35. Functional Stem Cell Integration into Neural Networks Assessed by Organotypic Slice Cultures
  36. Rho-associated kinase is a therapeutic target in neuroblastoma
  37. Abstract 5832: Rho-associated kinase is a therapeutic target in neuroblastoma
  38. Astrocytes release prostaglandin E2 to modify respiratory network activity
  39. Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity
  40. Maternal fetal loss history and increased acute leukemia subtype risk in subsequent offspring: a systematic review and meta-analysis
  41. Unexpected, unexplained and life-threatening events in infants are age-dependent descriptive syndromes with different risk and management
  42. Brainstem networks can be maintained functional in a dish
  43. Morbidité néonatale précoce après sortie de maternité : étude comparative entre deux maternités à Stockholm et Marseille
  44. Prostaglandin E2 Mediates Cardiorespiratory Disturbances during Infection in Neonates
  45. Prediction of Late Death or Disability at Age 5 Years Using a Count of 3 Neonatal Morbidities in Very Low Birth Weight Infants
  46. Adult neural precursor cells form connexin-dependent networks that improve their survival
  47. Extremely preterm infants who are small for gestational age have a high risk of early hypophosphatemia and hypokalemia
  48. Social Variables Predict Gains in Cognitive Scores across the Preschool Years in Children with Birth Weights 500 to 1250 Grams
  49. Predicting severe motor impairment in preterm children at age 5 years
  50. Evaluation of urinary prostaglandin E2 metabolite as a biomarker in infants with fever due to viral infection
  51. Il-1  and prostaglandin E2 attenuate the hypercapnic as well as the hypoxic respiratory response via prostaglandin E receptor type 3 in neonatal mice
  52. Reduction in Developmental Coordination Disorder with Neonatal Caffeine Therapy
  53. PGE2- metabolite levels in CSF correlate to HIE score and outcome after perinatal asphyxia
  54. Unexpected collapse of healthy newborn infants: risk factors, supervision and hypothermia treatment
  55. Sudden Unexpected Postnatal Collapse of Newborn Infants: A Review of Cases, Definitions, Risks, and Preventive Measures
  56. Stem cell integration into neural networks can be studied using organotypic cultures
  57. mPGES-1 and prostaglandin E2: vital role in inflammation, hypoxic response, and survival
  58. Survival Without Disability to Age 5 Years After Neonatal Caffeine Therapy for Apnea of Prematurity
  59. PRRT2 Mutations Cause Benign Familial Infantile Epilepsy and Infantile Convulsions with Choreoathetosis Syndrome
  60. Anti-Ro52 monoclonal antibodies specific for amino acid 200–239, but not other Ro52 epitopes, induce congenital heart block in a rat model
  61. The Caffeine for Apnea of Prematurity (CAP) Trial: Preliminary Outcomes at 5 Years
  62. Impact of Delivery Room Resuscitation on Outcomes up to 18 Months in Very Low Birth Weight Infants
  63. An inflammatory pathway to apnea and autonomic dysregulation
  64. Dynamic changes in connexin expression following engraftment of neural stem cells to striatal tissue
  65. Economic Evaluation of Caffeine for Apnea of Prematurity
  66. Hypoxic preconditioning increases gap-junctional graft and host communication
  67. Graft and host interactions following transplantation of neural stem cells to organotypic striatal cultures
  68. Premature expression of KCC2 in embryonic mice perturbs neural development by an ion transport-independent mechanism
  69. Caffeine for Apnea of Prematurity Trial: Benefits May Vary in Subgroups
  70. Stem cells rescue nerve cells by direct contact
  71. Cardiorespiratory development in extremely preterm infants: vulnerability to infection and persistence of events beyond term-equivalent age
  72. Long-Term Effects of Caffeine Therapy for Apnea of Prematurity
  73. The induced prostaglandin E 2 pathway is a key regulator of the respiratory response to infection and hypoxia in neonates
  74. SCN2A Mutations and Benign Familial Neonatal-Infantile Seizures: The Phenotypic Spectrum
  75. Caffeine Therapy for Apnea of Prematurity
  76. Communication via gap junctions underlies early functional interactions between grafted neural stem cells and the host
  77. Interleukin-1β depresses hypoxic gasping and autoresuscitation in neonatal DBA/1lacJ mice
  78. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block
  79. Development of neurotransmitter systems during critical periods
  80. 110 Reduced Expression of Microsomal Prostaglandin Synthase 1 Attenuates Ventilatory Effects of Interleukin-1â in Neonatal DBA/1LACJ Mice
  81. Congenital hypoventilation and impaired hypoxic response in Nurr1 mutant mice
  82. IL-1β Depresses Respiration and Anoxic Survival via a Prostaglandin-Dependent Pathway in Neonatal Rats
  83. Consequences of eliminating adenosine A1receptors in mice
  84. Perinatal Respiratory Control and Its Modulation by Adenosine and Caffeine in the Rat
  85. Neurotransmitters and neuromodulators during early human development
  86. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1receptor
  87. Effects of neuroactive substances on the morphine-induced respiratory depression; an in vitro study11Published on the World Wide Web on 23 October 2000.
  88. Maternal Caffeine Intake Has Minor Effects on Adenosine Receptor Ontogeny in the Rat Brain
  89. Adenosinergic modulation of respiratory neurones in the neonatal rat brainstemin vitro
  90. INFECTION AND INTERLEUKIN-1β VIA PROSTAGLANDIN E2 DEPRESSES RESPIRATION II: AN IN VIVO STUDY
  91. INFECTION AND INTERLEUKIN-1β VIA PROSTAGLANDIN E2 DEPRESSES RESPIRATION I: AN IN VITRO STUDY
  92. THE INTERACTION BETWEEN MORPHINE AND SOME NEUROACTIVE SUBSTANCES IN THE MEDULLARY RESPIRATION CENTER
  93. Age- and temperature-dependent effects of opioids on medulla oblongata respiratory activity: an in vitro study in newborn rat
  94. THE INTERACTION BETWEEN MORPHINE AND ACETYLCHOLINE IN THE MEDULLARY RESPIRATION-RELATED STRUCTURES
  95. Actions of opioids on respiratory activity via activation of brainstem μ-, δ- and κ-receptors; an in vitro study
  96. A1074 MU-1 OPIOID RECEPTOR IN THE MEDULLA OBLONGATA IS INVOLVED IN THE OPIOID-INDUCED RESPIRATORY DEPRESSION
  97. Adenosine Modulates Inspiratory Neurons and the Respiratory Pattern in the Brainstem of Neonatal Rats
  98. Neurotransmitters and neuromodulators
  99. The neonatal synaptic big bang